Company intelligence / Profile preview
SciSparc
Tel Aviv–Yafo, Tel Aviv District, Israelscisparc.com ↗
- Ownership
- Public · SPRC
- Employees
- ~2
- Development stage
- Phase 2
01
Overview
SciSparc is a clinical-stage specialty pharmaceutical company developing proprietary cannabinoid-based therapies for central nervous system disorders. Its lead candidate, SCI‑110, is in Phase 2 trials for Tourette syndrome and Alzheimer’s-related agitation. Other programs target autism spectrum disorder, status epilepticus, chronic pain, and rare mitochondrial diseases. The company has demonstrated improved efficacy and safety profiles in early clinical studies[1][3][4].
- Therapeutic areas
- PulmonologyPsychiatryNeurology
- Modalities
- Small moleculeSynthetic cannabinoidCombination therapy (e.g., cannabinoids + N-acylethanolamines)
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Procaps Group SAPolyrizon Ltd.Clearmind Medicine Inc.The Israeli Medical Center for Alzheimer’s
04
Financials
- Market cap
- $295K
- Total revenue
- $395K
- Enterprise value
- $-3.9M
Beyond the preview
Go deeper on SciSparc.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SciSparc.